Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic), and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America), The global Metagenomic Sequencing Market size is projected to reach a CAGR of 19.1% from 2023-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/metagenomic-sequencing-market
Regional Analysis
North America to Dominate the Market
· North America accounted for the largest share of the metagenomic sequencing market in 2021. Factors such as the increasing applications of metagenomics in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions are driving the growth of the metagenomic sequencing market in North America.
· The market in the Asia Pacific is expected to register the highest growth rate during the forecast period, primarily due to the increasing financial support from public as well as private agencies, the increasing number of NGS-based research projects, increasing awareness about precision medicine, and the rising prevalence of chronic diseases.
The prominent players in Metagenomic Sequencing Market are
· Illumina, Inc.
· Thermo Fisher Scientific, Inc.
· QIAGEN N.V.
· PerkinElmer
· Oxford Nanopore Technologies Ltd.
· BGI Group
· Macrogen Inc.
· GENEWIZ
· Eurofins Scientific
· Novogene Corporation and More
Recent Developments
In January 2021, Illumina, Inc. (US) collaborated with Helix to increase national surveillance infrastructure in the US to track the emergence and prevalence of novel strains of SARS-CoV-2 with support from the CDC.
In June 2020, Illumina (US) acquired BlueBee, a cloud-based software company that provides genomic analysis solutions for research and clinical customers. Through this acquisition, Illumina enhanced its capabilities to analyze and interpret the data produced by its sequencing systems.
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/metagenomic-sequencing-market
The need for microbiome analysis and an increased understanding of the importance of the microbiome to human health are driving the market for metagenomic sequencing, which is expanding quickly. Metagenomic sequencing is now more widely used in a variety of applications, including drug discovery, environmental monitoring, and disease diagnosis. This is because the development of high-throughput sequencing technologies has made it simpler and more affordable to sequence large amounts of genetic material from complex samples.
The market for metagenomic sequencing is predicted to continue expanding at a rapid clip, with North America being the largest regional market, followed by Europe and Asia-Pacific. Overall, the market for metagenomic sequencing offers enormous prospects for businesses engaged in the sector. Companies may obtain a competitive edge and take a piece of the expanding market by investing in R&D activities, releasing new goods, and developing strategic alliances and collaborations.
Key Findings of Metagenomic Sequencing Market:
· The product & service segment is further segmented into reagents & consumables, instruments, services, and analysis & data interpretation solutions. The reagents & consumables segment is expected to share and reach the highest CAGR during the forecast period. Factors such as the development and commercialization of high-quality reagents and kits and the continuous requirement of sequencing reagents by end users are expected to drive the growth of this segment in the market.
· The technology segment is further segmented into Shotgun Metagenomic Sequencing, 16S rRNA Sequencing, and Metatranscriptomics. 16S rRNA sequencing segment accounted for the largest share of the metagenomic sequencing market. The high accuracy and affordability offered by 16S rRNA sequencing, advancements in bioinformatics solutions, and the growing number of metagenomic research activities to identify and classify various bacterial strains are the major factors driving the growth of the 16S rRNA sequencing market.
· The application segment is further segmented into drug discovery, clinical diagnostics, soil microbiome applications, industrial applications, ecological & environmental applications, veterinary applications, and other applications. The drug discovery segment is expected to reach the highest CAGR during the forecast period. The surge in the segment is due to increasing research activities for novel drug discovery and growing collaborations between market players, academic institutions, and pharmaceutical companies for drug development.
Access Full Report: https://www.delvens.com/report/metagenomic-sequencing-market
In addition to the market data for Metagenomic Sequencing Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirement.
Access More Reports:
Medium-Voltage Inverters Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
